Advertisement
Canada markets close in 3 hours 46 minutes

  • S&P/TSX

    21,844.32
    -167.40 (-0.76%)
     

  • S&P 500

    5,051.86
    -18.69 (-0.37%)
     

  • DOW

    38,362.73
    -140.96 (-0.37%)
     

  • CAD/USD

    0.7288
    -0.0033 (-0.45%)
     

  • CRUDE OIL

    83.00
    -0.36 (-0.43%)
     

  • Bitcoin CAD

    88,862.66
    -2,618.02 (-2.86%)
     

  • CMC Crypto 200

    1,397.10
    -27.00 (-1.89%)
     

  • GOLD FUTURES

    2,337.00
    -5.10 (-0.22%)
     

  • RUSSELL 2000

    1,985.21
    -17.43 (-0.87%)
     

  • 10-Yr Bond

    4.6540
    +0.0560 (+1.22%)
     

  • NASDAQ

    15,655.04
    -41.60 (-0.26%)
     

  • VOLATILITY

    16.16
    +0.47 (+2.99%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6817
    -0.0019 (-0.28%)
     
MARKETS LIVE BLOG:

STOCKS SHED GAINS, TESLA SURGES DAY AFTER EARNINGS

Tesla shares jump after EV maker vows to speed up launch of more affordable models

U.S. CDC advisers could vote on Pfizer COVID-19 vaccine booster on Thursday

Reuters
·1 min read

Sept 22 (Reuters) - U.S. Centers for Disease Control and Prevention advisory panel could vote on the use of a third shot of Pfizer Inc and partner BioNTech SE's COVID-19 vaccine on Thursday, an agency official said while kicking off the two-day panel discussion on Wednesday.

The CDC's Advisory Committee on Immunization Practices (ACIP) is meeting on Sept 22-23 to discuss which Americans should get the third vaccine shot, should it be authorized for use by the Food and Drug Administration.

Pfizer has asked the FDA to approve the third shot for all people aged 16 and over, but a panel of outside advisors to the FDA last Friday said there was only evidence for a shot being needed by people aged 65 and older. The FDA has not yet said how it plans to proceed.

(Reporting by Manojna Maddipatla in Bengaluru)